- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Why Many Doctors Don't Follow "Best Practices"
For all their talk about evidence-based medicine, a lot of doctors don't follow the clinical guidelines set by leading medical groups.
For all their talk about evidence-based medicine, a lot of doctors don't follow the clinical guidelines set by leading medical groups.
Consider, for example, the case of cataract surgery. It's a fairly straightforward medical procedure: Doctors replace an eye's cloudy lens with a clear, prosthetic one. More than a million people each year in the US have the surgery—most of them older than 65.
"The procedure itself is relatively painless and quick," says Dr. Catherine Chen, an anesthesiologist and researcher at the University of California, San Francisco. She calls it the "prototypical low-risk surgery."
And since at least 2002, Dr Chen says, clinical guidelines have stipulated that no preoperative testing is needed before cataract surgery. A large study showed that procedures like chest X-rays, blood tests and EKGs—tests sometimes recommended when older people undergo more complicated surgeries—do not benefit someone who is simply having a cataract removed. But Dr Chen noticed that a lot of patients are having these preoperative tests done anyway.
Read more at NPR: http://n.pr/1EySjYC
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
